Back to Directory Linda Lambrecht Email linda.lambrecht@umassmed.edu Institution WNE Maternal Pediatric Adolescent AIDS CTU Title Clinical Laboratory Supervisor Request an Update Affiliated Studies P1010: Effect of Antiretroviral Therapy on Body Composition in Children. DAIDS Number 10814 Research Area Other Study Status Concluded P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded P1015: Cycling HAART in Pediatric/Adolescent Patients with < 50 HIV RNA copies/mL. DAIDS Number 10267 Research Area Other Study Status Concluded P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Concluded P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded Show All
P1010: Effect of Antiretroviral Therapy on Body Composition in Children. DAIDS Number 10814 Research Area Other Study Status Concluded
P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded
P1015: Cycling HAART in Pediatric/Adolescent Patients with < 50 HIV RNA copies/mL. DAIDS Number 10267 Research Area Other Study Status Concluded
P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Concluded
P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded